Skip to content

A study comparing mandukparni syrup and bimbi syrup for bedwetting in children aged 6 to 12 years.

Comparative clinical evaluation of mandukaparni syrup and bimbi syrup in the management of shayyamutra (nocturnal enuresis) in children of age group 6 12 years - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112110
Enrollment
70
Registered
2026-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F980- Enuresis not due to a substance orknown physiological condition

Interventions

None listed

Sponsors

MAMs Sumatibhai shah ayurved mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. History of bed-wetting atleast twice in a week or more for consecutive 3 months according to the DSM-V 2. The patient whose parents are willing for their child s participation in clinical trial by giving informed written consent/assent. 3. Patients with age group of 6 to12 years of either sex will be selected.

Exclusion criteria

Exclusion criteria: 1)Patients with any known case of: - ADHD - CNS disorders - Epilepsy - Spina Bifida 2)Endocrine/Metabolic disorders: - Diabetes Insipidus - Urinary tract infections 3)Any obstruction in lower urinary tract. 4)Patients with congenital anomalies of the genito-urinary tract 5) Patients below 6 years and above 12 years.

Design outcomes

Primary

MeasureTime frame
To evaluate and compare the clinical efficacy of mandukaparni syrup and bimbi syrup in the management of shayyamutra (nocturnal enuresis) among children aged 6 to 12 years given for 30 days.Timepoint: Treatment will be given for 30 days Follow up will be done on 7th, 15th, 30th, 45th days

Secondary

MeasureTime frame
1) To assess the improvement in frequency and severity of bedwetting episodes during the course of treatment in both groups. 2) To record and compare any adverse effects or safety concerns observed with Mandukaparni and Bimbi syrup.Timepoint: Treatment will be given for 30 days Follow up will be done on 7th, 15th, 30th, 45th days

Countries

India

Contacts

Public ContactDr Nitin R Waghmare

MAMs Sumatibhai shah ayurved mahavidyalaya

drnitinwaghmare@gmail.com9320383434

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026